Clinical Trial Update: Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease. [Phase 4]

View source ↗

Summary

Phase 4 trial studying aspirin and clopidogrel in healthy subjects with coronary artery disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Neil Kleiman, MD | Conditions: Coronary Artery Disease | Phase 4 | Status: WITHDRAWN